Frontiers: HIV and Sickle-Cell Disease
Funding Amount
Not stated
Deadline
Deadline not published
Grant Type
Foundation
Overview
A transformational fund through Gates Philanthropy Partners focused on solving HIV and sickle-cell disease, which are among the most prevalent and deadly diseases for children globally.
Focus Areas:
- Development of a single-shot cure for HIV
- Development of a single-shot cure for sickle-cell disease
- Creating treatments that are safe, effective, and affordable
- Ensuring access for all people regardless of geography
Geographic Scope: Global
Key Features:
- Bill & Melinda Gates Foundation will match 100% of gifts to this program
- Ambitious plan to end both diseases
- Newest fund offering from Gates Philanthropy Partners
- Supports innovation and frontier research
What Gates Philanthropy Partners actually gave
Source: IRS Form 990, 2024
- Grants in 2024
- 3
- Total given
- $1.9M
- Median grant
- $500K
- Range
- $250K–$1.15M
- By dollars: New York 61%, Washington 26%, California 13%. Top recipient cities: New York, NY; Seattle, WA; Menlo Park, CA.
Example grants
United States Fund for UNICEF · New York, NY
Polio eradication
$1.15M
University of Washington Foundation · Seattle, WA
Hiv frontiers & sickle cell disease
$500K
Menlo Education Research LLC · Menlo Park, CA
U.s. education
$250K
Focus Areas & Funding Uses
Fields of Work
- HIV/AIDS
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Stuntz Mycology Fund Small Grants
Daniel E Stuntz Memorial Foundation
Amount
Up to $1,000
Deadline
Rolling
Centers for Structural Biology of HIV and Other Infectious Diseases (U54 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Up to $3.5M
Deadline
May 28, 2027
Parkinson's Disease Therapeutics Pipeline Grant Program
The Michael J Fox Foundation for Parkinson's Research
Amount
US $250,000 - US $2,000,000
Deadline
October 30, 2026
Listed date — confirm with the funder
Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)
National Institutes of Health
Amount
Varies
Deadline
November 5, 2027
Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
November 16, 2027
Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 CT Not Allowed)
National Institutes of Health
Amount
$1,000,000 total
Deadline
October 20, 2028
Ready to apply for Frontiers: HIV and Sickle-Cell Disease?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Frontiers: HIV and Sickle-Cell Disease. Now let's win it.